CK2i treated cells, replicate 3
Mus musculus
source_name
CK2i treated_BM-drived HPC
strain
Lewis Lung Carcinoma (LLC)-tumor bearing (TB) mouse
treated with
60 mg/kg of CK2 inhibitor BMS-595 (CK2i) for 2 weeks
cell type
bone marrow derived hematopoietic progenitor cells (HPC)